Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

Fig. 7

Relation of SYNJ2 expression with disease-free interval and progression-free interval of cancers patients. A, B SYNJ2 expression is related to disease-free interval (A) and progression-free interval (B) of cancers patients based on the results of univariate Cox regression analysis. C, D SYNJ2 expression is related to disease-free interval (C) and progression-free interval (D) of cancers patients based on the results of Kaplan–Meier curves

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us